Guijarro L G, Couvineau A, Rodriguez-Pena M S, Juarranz M G, Rodriguez-Henche N, Arilla E, Laburthe M, Prieto J C
Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, Alcalá de Henares-Madrid, Spain.
Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):515-20. doi: 10.1042/bj2850515.
We describe the status of vasoactive intestinal peptide (VIP) receptors in regenerating liver. VIP-stimulated adenylate cyclase activity was markedly decreased in proliferating liver 3 days after partial (70%) hepatectomy. This was associated with a reduced efficacy of VIP (53% compared with controls), with no change in the potency of the peptide (ED50 0.8 nM). In contrast, forskolin- and guanosine 5'-[beta gamma-imido]triphosphate (Gpp[NH]p)-stimulated enzyme activities were not decreased after hepatectomy. The expression of Gs protein subunits (alpha and beta) was studied by cholera toxin-catalysed ADP ribosylation of alpha s and by immunoblotting of alpha s and beta subunits. Both subunits were increased in regenerating liver, further suggesting that the decreased response to VIP was not related to a decreased expression of Gs proteins. In fact, the reduced adenylate cyclase response to VIP in regenerating liver was associated with quantitative and structural changes in VIP receptors. Equilibrium binding data obtained with 125I-VIP indicated the presence of two classes of binding sites, the Kds of which were not altered after hepatectomy. In contrast, changes in binding capacity (Bmax.) were as follows: 0.11 +/- 0.01 and 0.05 +/- 0.01 pmol/mg of protein for high-affinity sites in control and hepatectomized rats respectively; and 2.3 +/- 0.2 and 0.65 +/- 0.03 pmol/mg of protein for low-affinity sites in control and hepatectomized rats respectively. Moreover, affinity labelling experiments showed that the M(r) value of 125I-VIP-receptor complexes was higher in regenerating liver than in quiescent hepatocytes, e.g. 58,000 and 53,000 respectively. It is concluded that VIP receptors are altered in regenerating liver, resulting in a decreased response of adenylate cyclase to the neuropeptide.
我们描述了再生肝脏中血管活性肠肽(VIP)受体的状态。部分(70%)肝切除术后3天,增殖肝脏中VIP刺激的腺苷酸环化酶活性显著降低。这与VIP的效力降低有关(与对照组相比降低了53%),而该肽的效能没有变化(ED50为0.8 nM)。相比之下,福斯可林和鸟苷5'-[βγ-亚氨基]三磷酸(Gpp[NH]p)刺激的酶活性在肝切除术后并未降低。通过霍乱毒素催化的αs的ADP核糖基化以及αs和β亚基的免疫印迹研究了Gs蛋白亚基(α和β)的表达。两个亚基在再生肝脏中均增加,进一步表明对VIP反应降低与Gs蛋白表达降低无关。事实上,再生肝脏中腺苷酸环化酶对VIP反应降低与VIP受体的数量和结构变化有关。用125I-VIP获得的平衡结合数据表明存在两类结合位点,肝切除术后其解离常数(Kd)未改变。相比之下,结合容量(Bmax.)的变化如下:对照组和肝切除大鼠中高亲和力位点分别为0.11±0.01和0.05±0.01 pmol/mg蛋白质;对照组和肝切除大鼠中低亲和力位点分别为2.3±0.2和0.65±0.03 pmol/mg蛋白质。此外,亲和标记实验表明,再生肝脏中125I-VIP-受体复合物的相对分子质量(M(r))值高于静止肝细胞,例如分别为58,000和53,000。结论是再生肝脏中的VIP受体发生改变,导致腺苷酸环化酶对该神经肽的反应降低。